With a hostile offer, BP don't get to see any internal data. That's why they're rare.
I'm more worried that any partnership agreement might be on bad terms due to ACW's fragile financial situation.
- Forums
- ASX - By Stock
- [INTERVIEW] Actinogen Medical reveals XanaCIDD phase 2a trials
ACW
actinogen medical limited
Add to My Watchlist
10.5%
!
2.1¢

With a hostile offer, BP don't get to see any internal...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
2.1¢ |
Change
0.002(10.5%) |
Mkt cap ! $66.72M |
Open | High | Low | Value | Volume |
1.9¢ | 2.3¢ | 1.9¢ | $216.6K | 10.28M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 524999 | 2.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.3¢ | 94082 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 524999 | 0.021 |
6 | 5399450 | 0.020 |
18 | 3667783 | 0.019 |
10 | 2665444 | 0.018 |
6 | 4292542 | 0.017 |
Price($) | Vol. | No. |
---|---|---|
0.023 | 94082 | 1 |
0.024 | 1708254 | 5 |
0.025 | 896667 | 4 |
0.026 | 1579999 | 4 |
0.027 | 98640 | 2 |
Last trade - 16.10pm 24/06/2025 (20 minute delay) ? |
Featured News
ACW (ASX) Chart |